TNH insider sells entire 5.3M stake as H1 losses widen to VND 71.1B

Overview

Hoang Tuyen, a board member of TNH Hospital Group JSC (TNH, HOSE), has registered to sell all 5.3 million TNH shares he holds, reducing his stake from 3.2% to 0%. The sale comes as the company reported a net loss of nearly VND 71.1 billion for H1 2026, widening from a VND 54.2 billion loss in the same period last year.

Key Facts

• Hoang Tuyen, board member, registered to sell 5,300,000 TNH shares, representing a 3.2% stake.
• Transaction window: September 11, 2026 to October 9, 2026, via negotiation and/or order matching.
• Purpose stated as personal share transfer needs.
• TNH H1 2026 net revenue: VND 276.1 billion, up 28% year-on-year.
• H1 2026 net loss: VND 71.1 billion, compared to a VND 54.2 billion loss in H1 2025.
• Total assets as of June 30, 2026: VND 3,025 billion, up 5.3% from year-start.
• Total liabilities: VND 1,341 billion, up 19.9%; borrowings and finance leases at VND 1,254.8 billion (93.6% of total liabilities).

What Happened

Hoang Tuyen, a member of the Board of Directors at TNH Hospital Group JSC (TNH, HOSE), has notified the exchange of his intention to sell his entire holding of over 5.3 million TNH shares. The sale is scheduled to take place from September 11, 2026 to October 9, 2026, using both negotiated and order-matching methods. If successful, Tuyen’s ownership will drop from 3.2% to 0%, effectively exiting the shareholder register.

In a separate development, TNH released its reviewed consolidated financial statements for the first half of 2026. Net revenue reached nearly VND 276.1 billion, a 28% increase year-on-year, driven by contributions from TNH Viet Yen Hospital and the pharmaceutical subsidiary. However, cost of goods sold rose 29% to over VND 273.1 billion, leaving gross profit at just under VND 3 billion, down 36%. Financial costs surged 34% to over VND 28.9 billion, mainly due to higher interest expenses on projects for TNH Viet Yen and TNH Lang Son hospitals. Selling expenses jumped 74% to nearly VND 5 billion, while administrative costs rose 18% to almost VND 40.1 billion.

Market Context

TNH shares closed at VND 8,140 on September 7, 2026. The company is listed on the Ho Chi Minh Stock Exchange (HOSE) in the healthcare sector. The insider sale and widening losses come amid a period of heavy capital expenditure, with fixed assets accounting for 58.1% of total assets and long-term assets under construction at VND 999 billion (33% of total assets). The company’s debt burden has increased, with borrowings representing over 93% of total liabilities.

Strategic Significance

The board member’s decision to sell his entire stake may signal a lack of confidence in the company’s near-term prospects, especially as losses are widening despite revenue growth. The company is in an expansion phase, with new hospital projects in Lang Son and Thai Nguyen driving up pre-operating costs and interest expenses. For long-term investors, the key question is whether these investments will eventually generate returns that justify the current debt load and operational losses. The insider sale adds to the negative sentiment, potentially pressuring the stock further.

What to Watch

• Completion of the insider sale: whether Hoang Tuyen actually sells all shares by October 9, 2026.
• Q3 2026 earnings report: whether revenue growth continues and losses narrow as new hospitals begin operations.
• Progress of TNH Lang Son and Thai Nguyen International Hospital Phase 3 projects: any delays or cost overruns.
• Debt levels and interest coverage: monitoring if the company can service its VND 1.25 trillion in borrowings.
• Any additional insider transactions or major shareholder changes following this sale.